Buzdar AU - Search Results

1

Staging of breast cancer in the neoadjuvant setting.

Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Jeruss JS, et al. Among authors: buzdar au. Cancer Res. 2008 Aug 15;68(16):6477-81. doi: 10.1158/0008-5472.CAN-07-6520. Cancer Res. 2008. PMID: 18701468 Free PMC article. Review.

2

Breast cancer in men.

Giordano SH, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Among authors: buzdar au. Ann Intern Med. 2002 Oct 15;137(8):678-87. doi: 10.7326/0003-4819-137-8-200210150-00013. Ann Intern Med. 2002. PMID: 12379069 Review.

3

Estrogen receptors and distinct patterns of breast cancer relapse.

Hess KR, Pusztai L, Buzdar AU, Hortobagyi GN. Hess KR, et al. Among authors: buzdar au. Breast Cancer Res Treat. 2003 Mar;78(1):105-18. doi: 10.1023/a:1022166517963. Breast Cancer Res Treat. 2003. PMID: 12611463

4

Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma.

Zhang F, Yang Y, Smith T, Kau SW, McConathy JM, Esteva FJ, Kuerer HM, Symmans WF, Buzdar AU, Hortobagyi GN, Pusztai L. Zhang F, et al. Among authors: buzdar au. Cancer. 2003 Apr 1;97(7):1758-65. doi: 10.1002/cncr.11245. Cancer. 2003. PMID: 12655533 Free article.

5

Sequential paclitaxel reduces recurrence and mortality in women with early breast cancer.

Buzdar AU, Hortobagyi GN. Buzdar AU, et al. Cancer Treat Rev. 2003 Oct;29(5):449-52. doi: 10.1016/s0305-7372(03)00167-1. Cancer Treat Rev. 2003. PMID: 12972364 Review. No abstract available.

6

Is breast cancer survival improving?

Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Giordano SH, et al. Among authors: buzdar au. Cancer. 2004 Jan 1;100(1):44-52. doi: 10.1002/cncr.11859. Cancer. 2004. PMID: 14692023 Free article.

7

Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.

Esteva FJ, Sahin AA, Smith TL, Yang Y, Pusztai L, Nahta R, Buchholz TA, Buzdar AU, Hortobagyi GN, Bacus SS. Esteva FJ, et al. Among authors: buzdar au. Cancer. 2004 Feb 1;100(3):499-506. doi: 10.1002/cncr.11940. Cancer. 2004. PMID: 14745865 Free article. Clinical Trial.

8

Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience.

Cristofanilli M, Gonzalez-Angulo AM, Buzdar AU, Kau SW, Frye DK, Hortobagyi GN. Cristofanilli M, et al. Among authors: buzdar au. Clin Breast Cancer. 2004 Feb;4(6):415-9. doi: 10.3816/cbc.2004.n.004. Clin Breast Cancer. 2004. PMID: 15023242

9

Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response.

Rajan R, Poniecka A, Smith TL, Yang Y, Frye D, Pusztai L, Fiterman DJ, Gal-Gombos E, Whitman G, Rouzier R, Green M, Kuerer H, Buzdar AU, Hortobagyi GN, Symmans WF. Rajan R, et al. Among authors: buzdar au. Cancer. 2004 Apr 1;100(7):1365-73. doi: 10.1002/cncr.20134. Cancer. 2004. PMID: 15042669 Free article. Clinical Trial.

10

Breast carcinoma in men: a population-based study.

Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Giordano SH, et al. Among authors: buzdar au. Cancer. 2004 Jul 1;101(1):51-7. doi: 10.1002/cncr.20312. Cancer. 2004. PMID: 15221988 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

542 results

Search Page